Literature DB >> 1555974

Epithelial ovarian cancer: the role of radiotherapy.

A J Dembo1.   

Abstract

Although several studies during the last 10-15 years have served to clarify the role of postoperative external beam radiotherapy in patients with ovarian cancer, the subject remains controversial. This paper will review the following topics: 1. Stage I Ovarian Cancer. 2. The rationale for selecting whole abdominopelvic radiotherapy over other forms of radiotherapy, such as pelvic or lower abdominal radiotherapy. 3. The choice of radiation technique. 4. The evidence that radiotherapy is curative in ovarian cancer. 5. The toxicity of abdominopelvic radiotherapy. 6. The criteria by which patients are selected for abdominopelvic radiotherapy. 7. Radiotherapy versus chemotherapy in early disease. 8. Consolidation radiotherapy after chemotherapy in advanced disease.

Entities:  

Mesh:

Year:  1992        PMID: 1555974     DOI: 10.1016/0360-3016(92)90777-f

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.

Authors:  Charles A Kunos; Michael W Sill; Thomas E Buekers; Joan L Walker; Jeanne M Schilder; S Diane Yamada; Steven E Waggoner; Mohammed Mohiuddin; Paula M Fracasso
Journal:  Gynecol Oncol       Date:  2011-02       Impact factor: 5.482

2.  Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian Cancer.

Authors:  Diala F Hamade; Alexis Espinal; Jian Yu; Brian J Leibowitz; Renee Fisher; Wen Hou; Donna Shields; Jan-Peter van Pijkeren; Amitava Mukherjee; Michael W Epperly; Anda M Vlad; Lan Coffman; Hong Wang; M Saiful Huq; Ravi Patel; Jason Huang; Joel S Greenberger
Journal:  Radiat Res       Date:  2022-07-01       Impact factor: 3.372

3.  Whole abdominopelvic radiotherapy in the palliative treatment of pseudomyxoma peritonei.

Authors:  P Berkovic; L van de Voorde; G De Meerleer; L Delrue; B Speleers; S Van Belle; K Vandecasteele
Journal:  Strahlenther Onkol       Date:  2013-12-06       Impact factor: 3.621

4.  Whole abdominal radiotherapy in ovarian cancer.

Authors:  Alberto Biete; Izaskun Valduvieco; Angels Rovirosa; Blanca Farrús; Francesc Casas; Carlos Conill
Journal:  Rep Pract Oncol Radiother       Date:  2010-03-23

5.  Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study.

Authors:  Nathalie Rochet; Meinhard Kieser; Florian Sterzing; Sonja Krause; Katja Lindel; Wolfgang Harms; Michael H Eichbaum; Andreas Schneeweiss; Christof Sohn; Juergen Debus
Journal:  BMC Cancer       Date:  2011-01-28       Impact factor: 4.430

Review 6.  Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future.

Authors:  Emma C Fields; William P McGuire; Lilie Lin; Sarah M Temkin
Journal:  Front Oncol       Date:  2017-08-21       Impact factor: 6.244

7.  Stereotactic body radiation therapy in the treatment of ovarian cancer.

Authors:  Roman O Kowalchuk; Michael R Waters; K Martin Richardson; Kelly Spencer; James M Larner; William P Irvin; Charles R Kersh
Journal:  Radiat Oncol       Date:  2020-05-13       Impact factor: 3.481

8.  Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low-dose fraction radiation.

Authors:  Lili Zhao; Shihai Liu; Donghai Liang; Tao Jiang; Xiaoyan Yan; Shengnan Zhao; Yuanwei Liu; Wei Zhao; Hongsheng Yu
Journal:  Cancer Med       Date:  2019-04-02       Impact factor: 4.452

9.  Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocol.

Authors:  Nathalie Rochet; Alexandra D Jensen; Florian Sterzing; Marc W Munter; Michael H Eichbaum; Andreas Schneeweiss; Christof Sohn; Juergen Debus; Wolfgang Harms
Journal:  BMC Cancer       Date:  2007-12-19       Impact factor: 4.430

10.  Treatment planning of epithelial ovarian cancers using helical tomotherapy.

Authors:  V Jamema Swamidas; Umesh Mahantshetty; Goel Vineeta; Reena Engineer; Deepak D Deshpande; Rajiv Sarin; Shyam Kishore Shrivastava
Journal:  J Appl Clin Med Phys       Date:  2009-10-07       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.